Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shionogi & Co (4507 JP)
Watchlist
188
Analysis
Health Care
•
Japan
Shionogi & Company Ltd., is a pharmaceutical company. The Company develops prescription & over-the-counter drugs and diagnostics.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Santos Ltd
•
22 Jun 2025 06:10
(Mostly) Asia-Pac M&A: Adriatic Metals, Carta, Mayne Pharma, PointsBet, Tourism Holdings
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
594 Views
Share
bearish
•
Mayne Pharma
•
16 Jun 2025 01:23
Merger Arb Mondays (16 June) - Mayne, Pointsbet, Fengxiang, HKBN, Seven & I, Shibaura, Smartpay
We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
1k Views
Share
bearish
•
Mayne Pharma
•
09 Jun 2025 01:14
Merger Arb Mondays (09 June) - Mayne, Tam Jai, OneConnect, Toyota Industries, Makino, Fuji Corp
We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
1.2k Views
Share
bearish
•
Seven & I Holdings
•
02 Jun 2025 01:23
Merger Arb Mondays (02 June) - Seven & I, SBI Sumishin, Shibaura, Mayne, ENN Energy, HKBN, Zeekr
We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
615 Views
Share
bullish
•
Shionogi & Co
•
27 May 2025 16:57
Shionogi & Co (4507 JP): Change Of Gears Likely From FY26, Torii Acquisition Augurs Well
Shionogi sees revenue rise in FY25 as royalties offset lower infectious disease drug sales. Acquisition and new drug submissions signal product...
Tina Banerjee
Follow
453 Views
Share
First
Previous
20
21
22
23
24
25
26
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x